Company Overview - Health In Tech (Nasdaq: HIT) is an Insurtech platform company that leverages third-party AI technology to enhance processes in the healthcare industry through vertical integration, process simplification, and automation [4]. - The company aims to streamline the underwriting, sales, and service processes for insurance companies, licensed brokers, and third-party administrators (TPAs) [4]. Event Participation - Health In Tech will participate as a Gold Sponsor at the American Trust Investment Services National Conference 2025, scheduled for June 16–18, 2025, in San Diego, California [1][2]. - The conference will focus on business growth, collaboration, and innovation in financial services, bringing together registered representatives, advisors, and preferred sponsors [2]. Strategic Vision - CEO Tim Johnson expressed excitement about the conference, highlighting it as an opportunity to connect with influential advisors and showcase how the company's platform enhances transparency, efficiency, and affordability in healthcare benefits [3]. - Health In Tech plans to engage in one-on-one meetings, interact with attendees in the vendor room, and present its strategic vision to raise awareness of its platform and its role in driving innovation in the healthcare industry [3].

Group 1 - Health In Tech, Inc. (Nasdaq: HIT) is an Insurtech platform company utilizing third-party AI technology to enhance healthcare processes [1][3] - The company will present at the "2025 Virtual Tech Conference" hosted by Maxim Group LLC from June 3rd to June 5th, with its presentation scheduled for June 3rd at 4:00 p.m. EDT [1] - The conference will focus on the impact of emerging technologies, including quantum computing and AI, on various industries, including healthcare [2] Group 2 - Health In Tech aims to streamline the underwriting, sales, and service processes for insurance companies, licensed brokers, and third-party administrators (TPAs) through vertical integration and automation [3] - Maxim Group LLC is a full-service investment banking and wealth management firm that provides a range of financial services, including investment banking and equity research [4]

Core Viewpoint - Octopus Titan VCT plc reported a disappointing total return of -14.1% for the year ending December 31, 2024, with net assets decreasing to £831 million, primarily due to company-specific performance issues and challenging market conditions [3][4][27]. Financial Summary - Net assets decreased from £993.74 million in 2023 to £831.358 million in 2024 [2]. - Loss after tax for the year was £147.649 million, slightly improved from £149.499 million in the previous year [2]. - NAV per share fell from 62.4p in 2023 to 50.5p in 2024, reflecting a decrease of 8.8p per share [2][3]. - Total value per share decreased from 164.4p in 2023 to 155.6p in 2024 [2][7]. - Total return per share was -8.8p, translating to a total return percentage of -14.1% for the year [2][7]. - Dividends paid in 2024 totaled 3.1p, down from 5.0p in 2023, resulting in a dividend yield of 5.0% [2][13]. Performance Analysis - The decline in NAV was attributed to underperformance of portfolio companies, particularly Pelago, Many Pets, and Big Health, which collectively accounted for about one-third of the total NAV decline [4][48][49]. - The five-year tax-free annual compound return for shareholders is now -3.5%, and since the high watermark at December 31, 2021, the total return per share has decreased by 39.8% [5][27]. - The company utilized £137 million of cash resources during the year, with £30 million allocated to new and follow-on investments [6]. Strategic Review - A strategic review was initiated in September 2024 to address performance challenges and develop a plan for future sustainability and improved performance [10][30]. - The review includes an analysis of historical investment performance, sustainability, future investment strategy, and team structure [10][34]. - The Board is considering feedback from a shareholder survey indicating significant dissatisfaction with past performance and capital growth opportunities [10][71]. Portfolio Management - The portfolio consists of over 135 companies, with 42% not expecting further funding needs, increasing to 67% when including those with more than 12 months' cash runway [29]. - In 2024, Titan completed 8 new investments and 14 follow-on investments totaling £30 million [68]. - The company returned £29 million in cash proceeds from exits during the year, which was below the level achieved in 2023 [28][56]. Governance and Management Changes - Erin Platts was appointed as the new CEO of Octopus Ventures in January 2025, bringing extensive experience from her previous role at HSBC Innovation Banking UK [41][42]. - The Board has acknowledged the turnover in the Octopus Ventures team and is assessing the team structure and culture as part of the ongoing strategic review [23][30].

Company Overview - HighPeak is an innovative, early-stage company leveraging AI technology, machine learning, and proprietary data to deliver accurate life planning data in the market [5] - The company is backed by Prudential Financial, a global financial services leader with approximately $1.5 trillion in assets under management as of December 31, 2024 [6] Leadership and Vision - Sharon Rodriguez, CEO of HighPeak, is leading efforts to transform financial planning for advisors by integrating healthcare costs, longevity insights, and financial risk analysis [1][2] - Rodriguez joined HighPeak in 2023 and has a multifaceted background as a corporate buyer, startup founder, and venture investor, equipping her to drive innovation and growth [3] Product and Technology - HighPeak provides an AI-powered platform that generates precise, real-time forecasts on healthcare costs, longevity, and financial risk, moving beyond traditional planning tools [2][4] - The platform aims to equip financial advisors with tools to anticipate future healthcare expenses confidently, enabling the creation of financial plans that reflect real-world health expenses [4] Market Strategy - HighPeak is focused on expanding partnerships and enhancing predictive capabilities to meet the growing demand for tailored financial planning solutions [4] - The company is launching solutions specifically designed for financial advisors, establishing a strong foundation for broader market expansion [3]